Role of COX-independent targets of NSAIDs and related compounds in cancer prevention and treatment

Prog Exp Tumor Res. 2003;37:261-85. doi: 10.1159/000071377.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • 3',5'-Cyclic-GMP Phosphodiesterases / antagonists & inhibitors
  • 3-Phosphoinositide-Dependent Protein Kinases
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antineoplastic Agents / pharmacology*
  • Cell Cycle / drug effects
  • Cyclic Nucleotide Phosphodiesterases, Type 2
  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • Enzyme Inhibitors / pharmacology*
  • Humans
  • I-kappa B Kinase
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • NF-kappa B / antagonists & inhibitors
  • Neoplasms / drug therapy
  • Neoplasms / enzymology
  • Neoplasms / prevention & control*
  • Phosphoric Diester Hydrolases / drug effects
  • Protein-Serine-Threonine Kinases / antagonists & inhibitors

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antineoplastic Agents
  • Enzyme Inhibitors
  • NF-kappa B
  • 3-Phosphoinositide-Dependent Protein Kinases
  • Protein-Serine-Threonine Kinases
  • CHUK protein, human
  • I-kappa B Kinase
  • IKBKB protein, human
  • IKBKE protein, human
  • Mitogen-Activated Protein Kinases
  • Phosphoric Diester Hydrolases
  • Cyclic Nucleotide Phosphodiesterases, Type 2
  • PDE2A protein, human
  • 3',5'-Cyclic-GMP Phosphodiesterases
  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • PDE5A protein, human